ArisGlobal

ArisGlobal is a technology company that provides essential solutions for life sciences research and development. Founded in 1987 and headquartered in Miami, Florida, it has become a leader in drug safety, clinical development, regulatory compliance, and medical affairs. The company’s LifeSphere® platform utilizes cognitive computing and machine learning to automate drug development workflows. With over 500 global clients, including pharmaceutical companies, contract research organizations, and regulatory agencies like the FDA, ArisGlobal employs 1,315 people and reported revenues of EUR 160 million for 2024. The LifeSphere® platform offers a range of services, including drug safety reporting, AI-driven clinical trial analytics, end-to-end regulatory submission management, and tools for medical literature monitoring. The company is also integrating generative AI to enhance research and regulatory processes. ArisGlobal has experienced strategic growth through acquisitions, such as Amplexor and SPORIFY, which have strengthened its regulatory capabilities. The company is committed to sustainability, social equity, and innovation in the life sciences sector.